Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Trial Results
Biotech
Pfizer ‘comfortable’ joining fights with hantavirus, Ebola: exec
As Pfizer endeavors to stymie a suite of bacterial infections, the COVID-19 vaccine maker continues to keep an eye on emerging public health threats.
Darren Incorvaia
May 20, 2026 5:05am
Regenxbio reaps pivotal win for Duchenne gene therapy
May 14, 2026 7:25am
Mirum maps FDA path after anti-itch candidate scores ph. 2 win
May 4, 2026 10:40am
Maze stock plummets after potential 'best-in-class' ph. 2 data
Mar 25, 2026 10:57am
Ocugen eye disease gene therapy nabs ph. 2 win
Mar 24, 2026 10:40am
Genentech shreds RIPK1 inhibitor after ph. 2 failure
Mar 19, 2026 2:48pm
